Cosmetic, Supplement or Medical Device? How Product Classification Decides Your Regulatory Path

Quick answer: A product's regulatory category is decided by what it is intended to do and how it works — not by what it is made of, what it looks like, or what the brand owner would prefer to call it. In Malaysia, the same cream can be a notified cosmetic, a registered medicinal product or an unregistrable claim, depending on the wording on the label. Classification determines the approval route, the testing bill, the factory that can legally make it, and the launch date. It should be settled before formulation starts, not after the first batch is filled.

Key takeaways

• Intended use drives classification. Claims, not ingredients, are usually the deciding factor.
• Four common pathways apply to Malaysian health and beauty products: cosmetic notification, health supplement or traditional product registration, food compliance, and medical device registration.
• Each pathway has a different regulator, timeline and evidence burden. They are not interchangeable, and a factory approved for one is not automatically approved for another.
• Borderline products are common — scar gels, anti-acne serums, collagen drinks, hand sanitisers and slimming products sit near category lines.
• Misclassification is expensive late. The cost is rarely a fine; it is usually a rewritten label, a re-run batch, a lost season, or a formula that has to be rebuilt from scratch.

Why does product classification matter before formulation starts?

Most brand owners arrive at a manufacturer with a product concept and a target price. Classification is treated as paperwork — something the regulatory team will sort out near the end. In practice it is the earliest and most structural decision in the project, because it sets constraints that formulation cannot undo later.

A cosmetic and a registered medicinal product are not two versions of the same thing. They differ in the permitted ingredient list, the concentration ceilings, the required manufacturing licence, the documentation retained, the label content, the shelf-life evidence, and the time between submission and permission to sell. Changing category mid-project usually means restarting development, not adjusting it.

The sequence that causes the fewest problems is: define the claim, confirm the category, then formulate to that category. The sequence most commonly seen is the reverse — formulate, write marketing copy, then discover the copy has moved the product into a category the formula and the factory cannot support.

What actually decides a product's classification?

Intended use and claims

Across most regulatory systems, the primary test is intended use: what the product is presented as doing. The United States Food and Drug Administration states the principle plainly in its guidance on whether a product is a cosmetic, a drug, or both: a product intended to cleanse or beautify is a cosmetic, while a product intended to treat or prevent disease, or to affect the structure or function of the body, is a drug — and the same article can be both. Malaysian practice follows the same logic even though the statutes differ.

This is why claims are not a marketing decision that sits downstream of development. A moisturiser that "hydrates dry skin" is a cosmetic. The same formula sold as a product that "treats eczema" is making a medicinal claim, and the category changes with it. The formula did not move; the intended use did. The mechanics of what may and may not be said are covered separately in Marketing Claims for Health and Beauty Products: What Brands Can Legally Say.

Ingredients and their concentration

Ingredients matter, but usually as a secondary filter. Some substances are prohibited in cosmetics outright. Others are permitted only below a threshold, above which the product is no longer a cosmetic. Malaysia applies the ASEAN Cosmetic Directive annexes through the National Pharmaceutical Regulatory Agency (NPRA), which maintains the lists of prohibited and restricted ingredients and the conditions attached to each.

The practical consequence is that concentration can silently reclassify a product. A well-known active at a cosmetic-permitted level is one submission; the same active at a therapeutic level is a different submission entirely, with a different evidence file behind it.

Route of administration and mode of action

The third filter separates supplements, foods and medical devices. A product taken orally to supplement the diet follows one route. The same benefit delivered by a physical or mechanical action — a barrier, an absorbent, a device that measures something — is likely to be a medical device. The World Health Organization defines a medical device by the fact that its principal intended action is not achieved by pharmacological, immunological or metabolic means. That single distinction resolves a large share of borderline cases.

How do the four pathways differ in Malaysia?

The table below summarises the four routes most Malaysian health and beauty brands encounter. Details change as regulations are revised, so the current regulator guidance should always be checked before a submission is planned.

Category	Regulator	Approval mechanism	Typical evidence burden
Cosmetic	NPRA	Notification (no pre-market approval of efficacy)	Safety substantiation and a Product Information File held by the notification holder
Health supplement / traditional product	NPRA (Drug Control Authority)	Registration, with a registration number issued before sale	Full product dossier: formulation, specifications, stability, manufacturing licence, claim justification
Food / functional food and beverage	Food Safety and Quality Division, Ministry of Health	No product registration; compliance with food legislation and labelling rules	Compositional and contaminant compliance, permitted additives, nutrition labelling, permitted claims
Medical device	Medical Device Authority	Registration by risk class, plus establishment licensing for manufacturers and distributors	Conformity assessment, quality management system, risk file, clinical or performance evidence

Cosmetics

Cosmetic notification is the lightest of the four routes, and it is frequently misunderstood as a form of government approval. It is not. Notification records the product with the regulator; responsibility for safety and for the accuracy of every claim stays with the notification holder. That distinction, and the file that must sit behind it, is explained in The Product Information File: What Cosmetic Brand Owners Must Keep.

Health supplements and traditional products

Registration is a materially heavier process than notification. A dossier is assessed before a registration number is granted, and the product cannot legally be sold until it is. Timelines are measured in months rather than weeks, and they depend on queue length and on how complete the first submission was. Brands that treat registration as a formality routinely underestimate this stage when planning a launch date.

Food and functional food

Food products carry no pre-market registration in Malaysia, which makes this route look like the fastest. It is faster to market, but it is not lighter in obligation: composition, contaminants, permitted additives, nutrition labelling and claim restrictions all apply from the first unit sold, and enforcement happens post-market. The absence of a gate does not mean the absence of a rule.

Medical devices

Medical devices are regulated by the Medical Device Authority under the Ministry of Health, with products assigned to risk classes and manufacturers required to hold establishment licences. The quality system expectation is different too: device manufacturing is typically built around ISO 13485 rather than the cosmetic or supplement GMP frameworks. A factory's certifications are category-specific, and a brand assessing whether a plant can legally make its product should read a manufacturer's certification scope against the intended category rather than assuming that any recognised certificate covers everything.

Where do brands most often get classification wrong?

Certain product types sit close enough to a category line that the wording of a single sentence moves them across it. The recurring examples in the Malaysian market include:

• Scar and wound gels. A cosmetic "improves the appearance of scars". A product that "heals wounds" is claiming a therapeutic action. A gel that works by forming a physical barrier over the skin may be a medical device rather than either.
• Anti-acne and anti-dandruff products. Cosmetic in some presentations, medicinal in others, depending on the active, its concentration and the claim.
• Collagen and beauty drinks. Sold as a beverage, they follow food rules. Sold with a dose, a course and a health claim, they move toward supplement registration.
• Hand sanitisers and antiseptics. The category depends on the claim and the active concentration; a cleansing claim and a germ-kill claim are not the same regulatory object.
• Slimming, whitening and firming products. Structure-and-function claims frequently push these past the cosmetic boundary.

What these have in common is that the brand owner rarely intends to make a medicinal claim. The claim arrives later, from a marketing team writing copy for a product that was developed and notified as a cosmetic. By then the label is printed, the notification is filed, and the copy either has to be cut or the product has to change category.

What does misclassification actually cost?

The cost is rarely the headline penalty. It is the sequence of consequences that follow from discovering the problem late:

• Rewritten artwork and reprinted packaging. Print runs are ordered in bulk; a claim that has to be removed can obsolete the entire order. Label content requirements are themselves category-specific, as set out in Product Labelling for Health and Beauty Brands: What Must Appear on the Pack.
• A formula that cannot be carried across. A cosmetic formula does not automatically qualify as a supplement or a device, and vice versa. Reclassification often means redevelopment.
• A factory that cannot make the new category. Manufacturing licences and certifications are scope-limited. A change of category can mean a change of manufacturer.
• A lost launch window. Registration timelines are outside the brand's control. A product that missed its season is a working capital problem long before it is a compliance problem.
• Export complications. Category assignment is not identical across markets, and a product classified one way in Malaysia may be classified differently elsewhere — a point examined in Exporting Health and Beauty Products from Malaysia.

How should a brand settle classification before development begins?

A workable method is to write the strongest claim the brand intends to make — the sentence that will appear on the front of the pack and in the advertising, not the cautious version in the internal brief — and classify against that sentence. Categories are set by the boldest claim, not the mildest one.

From there, three questions resolve most cases. What is the product presented as doing? By what mechanism does it achieve that? And do any ingredients, at the intended concentrations, carry restrictions of their own? Where the answers place a product genuinely on a boundary, a documented classification assessment — the kind of work handled under regulatory affairs consulting — is completed before a formulation brief is issued, so that the development target and the submission route are agreed at the same time.

Two habits reduce the risk further. The first is to involve whoever writes the marketing copy at the classification stage rather than after the product exists, because that person controls the variable the regulator will assess. The second is to record the classification decision and its reasoning in writing. When a product is questioned two years later, a dated rationale is worth considerably more than a recollection. The foundational rules for the cosmetic route specifically are set out in Cosmetic Compliance 101: What Every Beauty Founder Must Know Before Selling.

Frequently asked questions

Can one product be registered in two categories at once?

Generally, no — a single product presentation is assigned one category. A brand can, however, market two distinct products built on related formulas, each classified and submitted separately with its own claims and label. This is a common strategy, but it requires two development files and two submissions, not one product with two labels.

If the ingredients are all natural, is it automatically a cosmetic or a food?

No. Natural origin has no bearing on classification. A botanical extract with a therapeutic claim attached is treated as a medicinal claim, and several natural substances are themselves restricted or prohibited in cosmetics.

Who is responsible if a product turns out to be misclassified — the brand or the manufacturer?

Responsibility depends on the contract and on who holds the notification or registration, but the party named on the submission carries the regulatory obligation. That is normally the brand owner. A manufacturer may advise on classification and will usually decline work outside its licensed scope, but advice does not transfer legal responsibility.

How long does registration take compared with notification?

Cosmetic notification is typically resolved in a matter of weeks when the submission is complete. Registration of a health supplement or traditional product is normally measured in months, and medical device registration varies substantially by risk class. Any figure quoted more precisely than that should be confirmed against current regulator guidance, because processing times move.

Does changing a claim after launch require a new submission?

It can. A cosmetic claim change that stays within the cosmetic category may only require the Product Information File to be updated. A claim change that crosses a category line makes the product a different regulatory object, requiring a new submission under the correct route.

Sources and further reading

• National Pharmaceutical Regulatory Agency (NPRA), Malaysia — npra.gov.my
• Medical Device Authority, Ministry of Health Malaysia — mda.gov.my
• United States Food and Drug Administration — Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)
• World Health Organization — Medical devices

Limitations: this article describes general principles and the broad shape of Malaysian regulatory pathways as understood at the time of writing. Regulations, thresholds and processing times are revised periodically, and classification of a specific product depends on its full formulation, presentation and claims. Current regulator guidance should be checked before any submission, and specific products should be assessed individually.

---

Creaton Poh is the pen name of Poh Tze Kheng, founder of ORIZI Group — one of Malaysia's most comprehensive one-stop OEM, ODM, private label and contract manufacturing groups, spanning skincare, cosmetics, personal care, perfume and fragrance, supplements, functional food and nutrition, pet care, home care and medical devices. Across six specialised companies and three manufacturing divisions, the Group brings together 20+ years of industry experience, 5,000+ formulations, and internationally recognised quality, manufacturing and regulatory standards. These articles are written to educate, not to promote.

Written by Creaton Poh
Industry Researcher • Author • Vlogger • Manufacturing Strategist
Turning ideas into products. Turning experience into knowledge.

Connect with Poh Tze Kheng on LinkedIn.